156 related articles for article (PubMed ID: 9607850)
21. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
22. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
Mbow ML; Bleyenberg JA; Hall LR; Titus RG
J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534
[TBL] [Abstract][Full Text] [Related]
23. American cutaneous leishmaniasis: In situ immune response of patients with recent and late lesions.
Gomes AHS; Martines RB; Kanamura CT; Barbo MLP; Iglezias SD; Lauletta Lindoso JA; Pereira-Chioccola VL
Parasite Immunol; 2017 Apr; 39(4):. PubMed ID: 28239875
[TBL] [Abstract][Full Text] [Related]
24. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
25. Cytokine gene expression in healing and non-healing cases of cutaneous leishmaniasis in response to in vitro stimulation with recombinant gp63 using semi-quantitative RT-PCR.
Habibi GR; Khamesipour A; McMaster WR; Mahboudi F
Scand J Immunol; 2001 Oct; 54(4):414-20. PubMed ID: 11555409
[TBL] [Abstract][Full Text] [Related]
26. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
Skeiky YA; Guderian JA; Benson DR; Bacelar O; Carvalho EM; Kubin M; Badaro R; Trinchieri G; Reed SG
J Exp Med; 1995 Apr; 181(4):1527-37. PubMed ID: 7699334
[TBL] [Abstract][Full Text] [Related]
27. TNF-alpha mediates the induction of nitric oxide synthase in macrophages but not in neutrophils in experimental cutaneous leishmaniasis.
Fonseca SG; Romão PR; Figueiredo F; Morais RH; Lima HC; Ferreira SH; Cunha FQ
Eur J Immunol; 2003 Aug; 33(8):2297-306. PubMed ID: 12884305
[TBL] [Abstract][Full Text] [Related]
28. Assessment of intralesional cytokine profile of cutaneous leishmaniasis caused by Leishmania donovani in Sri Lanka.
Galgamuwa LS; Sumanasena B; Iddawela D; Wickramasinghe S; Yatawara L
BMC Microbiol; 2019 Jan; 19(1):14. PubMed ID: 30642262
[TBL] [Abstract][Full Text] [Related]
29. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans.
Piedrafita D; Proudfoot L; Nikolaev AV; Xu D; Sands W; Feng GJ; Thomas E; Brewer J; Ferguson MA; Alexander J; Liew FY
Eur J Immunol; 1999 Jan; 29(1):235-44. PubMed ID: 9933105
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease.
Titus RG; DeKrey GK; Morris RV; Soares MB
Infect Immun; 2001 Aug; 69(8):5189-92. PubMed ID: 11447205
[TBL] [Abstract][Full Text] [Related]
31. In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis.
Melby PC; Andrade-Narvaez F; Darnell BJ; Valencia-Pacheco G
FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):101-7. PubMed ID: 8880134
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis.
Melby PC; Andrade-Narvaez FJ; Darnell BJ; Valencia-Pacheco G; Tryon VV; Palomo-Cetina A
Infect Immun; 1994 Mar; 62(3):837-42. PubMed ID: 8112853
[TBL] [Abstract][Full Text] [Related]
33. American tegumentary leishmaniasis: mRNA expression for Th1 and Treg mediators are predominant in patients with recent active disease.
Souza MA; Almeida TM; Castro MC; Oliveira-Mendes AP; Almeida AF; Oliveira BC; Rocha LF; Medeiros AC; Brito ME; Dessein AJ; Pereira VR
Immunobiology; 2016 Feb; 221(2):253-9. PubMed ID: 26572279
[TBL] [Abstract][Full Text] [Related]
34. Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections.
Kostka SL; Knop J; Konur A; Udey MC; von Stebut E
J Invest Dermatol; 2006 Jul; 126(7):1582-9. PubMed ID: 16645594
[TBL] [Abstract][Full Text] [Related]
35. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.
Vieira LQ; Goldschmidt M; Nashleanas M; Pfeffer K; Mak T; Scott P
J Immunol; 1996 Jul; 157(2):827-35. PubMed ID: 8752935
[TBL] [Abstract][Full Text] [Related]
36. The regulation of immunity to Leishmania major.
Reiner SL; Locksley RM
Annu Rev Immunol; 1995; 13():151-77. PubMed ID: 7612219
[TBL] [Abstract][Full Text] [Related]
37. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
[TBL] [Abstract][Full Text] [Related]
38. IFNG +874T/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-gamma production.
Matos GI; Covas Cde J; Bittar Rde C; Gomes-Silva A; Marques F; Maniero VC; Amato VS; Oliveira-Neto MP; Mattos Mda S; Pirmez C; Sampaio EP; Moraes MO; Da-Cruz AM
BMC Infect Dis; 2007 Apr; 7():33. PubMed ID: 17456233
[TBL] [Abstract][Full Text] [Related]
39. Human polymorphonuclear leukocytes produce cytokines in response to Leishmania major promastigotes.
Keyhani A; Riazi-Rad F; Pakzad SR; Ajdary S
APMIS; 2014 Sep; 122(9):891-7. PubMed ID: 24698213
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis.
Ramírez L; Santos DM; Souza AP; Coelho EA; Barral A; Alonso C; Escutia MR; Bonay P; de Oliveira CI; Soto M
Vaccine; 2013 Feb; 31(9):1312-9. PubMed ID: 23313653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
